VEGFA and soft tissue sarcoma: Small molecule tyrosine kinase inhibitors of VEGF receptors, soluble VEGF receptors which act as decoy receptors for VEGF, and ribozymes which specifically target VEGF mRNA can also block VEGF pathway.75 Olimab, a human IgG1 antibody that binds to platelet‐derived growth factor receptor α (PDGFR‐α), is a new drug for soft tissue sarcomas.